Skip to content

Author

You-Sheng Mao

We have 2 of 52 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Comparison and validation of two proposed modifications to the current lymph node classification for esophageal squamous cell carcinoma.

BACKGROUND Accurate lymph node (LN) classification is crucial for prognostic evaluation and individualized management in esophageal squamous cell carcinoma (ESCC). METHODS We retrospectively analyzed 688 ESCC patients who underwent R0 resection without neoadjuvant therapy, dividing them into development (n = 461) and...

L. Fu, Li-Gong Yuan, Donghui Jin et al. · 0 citations
Review Open access Aug 2026

Circulating tumor DNA dynamics and mutational profiles as indicators in neoadjuvant chemoimmunotherapy for resectable or borderline resectable non-small cell lung cancer

Longitudinal ctDNA assessment identified high-risk subgroups in neoadjuvant NSCLC, particularly by refining prognosis in heterogeneous SD populations, and an exploratory gene-based mutational signature provided potential molecular risk stratification.

Wenxin Jiang, Si-Yu Lei, Sijie Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.